Can pretreatment ADC values predict recurrence of bladder cancer after transurethral resection?

European Journal of Radiology

Volumn 81, Issue 11, 2012, Pages 3115-3119

  Funatsu, Hiroyuki ^a   Imamura, Akihiro ^a   Takano, Hideyuki ^a   Ueda, Takeshi ^a   Uno, Takashi ^b  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Bladder cancer; Diffusion magnetic resonance imaging; Recurrence; ROC curve; Sensitivity and specificity

Indexed keywords

ARTICLE; BLADDER CANCER; BLADDER SURGERY; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSURETHRAL RESECTION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84866983379     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2012.06.009     Document Type: Article

References (22)

1. J. Ferlay, F. Bray, P. Pisani, and D.M. Parkin GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5. version 2.0. 2004 IARC Press Lyon
2. J.N. Eble, G. Sauter, and J.I. Epstein Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004 IARC Press Lyon
3. M. Maffezzini, R.J. Sylvester, and P.M. Adrian Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials European Urology 50 2006 623 624
4. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Bohle, and J. Palou-Redorta EAU guidelines on non muscle-invasive urothelial carcinoma of the bladder, the 2011 update European Urology 59 2011 997 1008
5. C. Mian, and A. Pychaa Risk stratification in superficial bladder cancer: fact or fiction EAU-EBU Update Series 5 2007 63 69
6. A.R. Padhani, G. Liu, and D. Mu-Koh Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2009 102 125
7. M. Matsuki, Y. Inada, F. Tatsugami, M. Tanikake, I. Narabayashi, and Y. Katsuoka Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results European Radiology 17 2007 201 204
8. H. Watanabe, M. Kanematsu, and H. Kondo Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? American Journal of Roentgenology 192 2009 1361 1366
9. M. Daggulli, M.R. Onur, F. Firdolas, R. Onur, E. Kocakoc, and I. Orhan Role of diffusion MRI and apparent diffusion coefficient measurement in the diagnosis, staging and pathological classification of bladder tumors Urologia Internationalis 87 2011 346 352
10. S. Kobayashi, F. Koga, and S. Yoshida Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness European Radiology 21 2011 2178 2186
11. B. Zelhof, M. Pickles, and G. Liney Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer BJU International 103 2009 883 888
12. X.Z. Wang, B. Wang, and Z.Q. Gao Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation Journal of Magnetic Resonance Imaging 29 2009 1360 1366
13. A.B. Rosenkrantz, T.C. Mussi, B. Spieler, J. Melamed, S.S. Taneja, and W.C. Huang High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results Journal of Magnetic Resonance Imaging 2012
14. R. Fluss, D. Faraggi, and B. Reiser Estimation of the Youden Index and its associated cutoff point Biometrical Journal 47 2005 458 472
15. C. Hafner, R. Knuechel, R. Stoehr, and A. Hartmann Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies International Journal of Cancer 101 2002 1 6
16. N.M. deSouza, S.F. Riches, and N.J. Vanas Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer Clinical Radiology 63 2008 774 782
17. 2 Acta Oncologica 36 1997 183 189
18. S.C. Chang, P.H. Lai, and W.L. Chen Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI Clinical Imaging 26 2002 227 236
19. M. Naik, A.D. Hardie, H. Chandarana, and C.H. Hajdu Diffusion-weighted imaging for detection and staging of urothelial neoplasms Proceedings of the International Society of Magnetic Resonance in Medicine 16 2008 2760
20. M. Takeuchi, S. Sasaki, and M. Ito Urinary bladder cancer: diffusion-weighted MR imaging - accuracy for diagnosing T stage and estimating histologic grade Radiology 251 2009 112 121
21. J.O. Barentsz, G.J. Jager, and P.B. van Vierzen Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging Radiology 201 1996 185 193
22. Y. Fujii, I. Fukui, K. Kihara, T. Tsujii, Y. Kageyama, and H. Oshima Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer European Urology 36 1999 309 313